\-\ Texto\\:\\ \ \(0\)\
\-\ dermoid\\ cysts\\ rarely\\ undergo\\ malignant\\ degeneration\\ \\(0\\.17\\-2\\%\\)\\,\\ however\\ complete\\ surgical\\ removal\\ via\\ laparotomy\\ or\\ laparoscopy\\ is\\ the\\ treatment\\ of\\ choice\\ secondary\\ to\\ the\\ risk\\ of\\ torsion\\ and\\/or\\ rupture\\.\\ \\ histopathologic\\ evaluation\\ of\\ the\\ specimen\\ should\\ follow\\ removal\\;\\ if\\ immature\\ elements\\ are\\ found\\ in\\ the\\ specimen\\,\\ then\\ standard\\ staging\\ should\\ be\\ performed\\.\ \(0\)\
\-\ pelvic\\ ultrasound\\ \\â\\€\\“\\ 2\\.6\\ x\\ 2\\.3\\ x\\ 2\\.3\\ cm\\ hyperechoic\\ right\\ ovarian\\ lesion\\.\ \(0\)\
\-\ ct\\,\\ abdomen\\/pelvis\\ w\\/\\ iv\\ contrast\\ \\â\\€\\“\\ 2\\.1\\ x\\ 2\\.5\\ cm\\ mass\\ in\\ right\\ ovary\\ containing\\ fat\\ attenuation\\,\\ most\\ consistent\\ with\\ a\\ dermoid\\ cyst\\.\ \(0\)\
\-\ ovarian\\ dermoid\\ cyst\ \(1\)\
\-\ dermoid\\ cyst\\ \\(benign\\ cystic\\ teratoma\\)\ \(1\)\
\-\ hemorrhagic\\ cyst\ \(15\)\
\-\ mucinous\\ cystadenoma\ \(9\)\
\-\ endometrioma\ \(17\)\
\-\ ovarian\\ carcinoma\ \(6\)\
\-\ 40\\ yo\\ ad\\ female\\ with\\ an\\ asymptomatic\\ right\\ ovarian\\ mass\\ identified\\ during\\ a\\ pelvic\\ ultrasound\\ for\\ uterine\\ fibroids\\.\ \(0\)\
\-\ dermoid\\ cysts\\,\\ also\\ called\\ benign\\ cystic\\ teratomas\\,\\ are\\ the\\ most\\ common\\ benign\\ ovarian\\ tumors\\.\\ \\ these\\ cysts\\ are\\ neoplastic\\ tumors\\ derived\\ from\\ germ\\ cells\\ and\\ contain\\ differentiated\\ tissue\\ from\\ the\\ three\\ germ\\ cell\\ layers\\:\\ ectoderm\\,\\ mesoderm\\ and\\ endoderm\\.\\ \\ most\\ commonly\\ found\\ are\\ endodermal\\ elements\\ such\\ as\\ skin\\,\\ sweat\\ and\\ sebaceous\\ glands\\,\\ hair\\,\\ and\\ sebum\\.\\ \\ teeth\\,\\ bone\\,\\ fat\\,\\ and\\ endocrine\\ tissue\\ may\\ also\\ be\\ found\\ in\\ these\\ cysts\\.\ \(0\)\
\-\ dermoid\\ cysts\\ are\\ oftentimes\\ identified\\ incidentally\\ on\\ routine\\ pelvic\\ exam\\.\\ \\ cysts\\ are\\ usually\\ asymptomatic\\,\\ unilateral\\,\\ nontender\\,\\ and\\ mobile\\.\\ \\ pelvic\\ ultrasound\\ is\\ the\\ initial\\ modality\\ used\\ to\\ evaluate\\ the\\ mass\\.\\ \\ imaging\\ most\\ commonly\\ reveals\\ a\\ complex\\,\\ predominantly\\ solid\\ mass\\ with\\ echogenic\\ internal\\ components\\ \\(i\\.e\\.\\ bone\\,\\ fat\\)\\,\\ but\\ may\\ also\\ vary\\ from\\ completely\\ cystic\\ to\\ completely\\ solid\\ depending\\ on\\ the\\ contents\\ of\\ the\\ cyst\\.\\ \\ cysts\\ containing\\ large\\ amounts\\ of\\ fat\\ are\\ associated\\ with\\ hypoechoic\\ distal\\ shadowing\\ as\\ was\\ seen\\ in\\ this\\ patient\\.\\ \\ pelvic\\ computed\\ tomography\\ is\\ a\\ helpful\\ adjunct\\ to\\ assist\\ in\\ identifying\\ the\\ cyst\\ contents\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cysts\\:\\ 0\\.3138002649227844\ \(0\)\
\-\ dermoid\\:\\ 0\\.2998255875522822\ \(0\)\
\-\ ovarian\\:\\ 0\\.25200063252934485\ \(0\)\
\-\ pelvic\\:\\ 0\\.23121978768083898\ \(0\)\
\-\ cyst\\:\\ 0\\.20475802180305222\ \(0\)\
\-\ are\\:\\ 0\\.1571356281701646\ \(0\)\
\-\ fat\\:\\ 0\\.14720086076444502\ \(0\)\
\-\ the\\:\\ 0\\.12984683046991483\ \(0\)\
\-\ specimen\\:\\ 0\\.1260666370839967\ \(0\)\
\-\ most\\:\\ 0\\.12315142594497418\ \(0\)\
\-\ benign\\:\\ 0\\.12191361745523947\ \(0\)\
\-\ contents\\:\\ 0\\.11832582993567517\ \(0\)\
\-\ elements\\:\\ 0\\.11733004783738492\ \(0\)\
\-\ found\\:\\ 0\\.11483467001768155\ \(0\)\
\-\ germ\\:\\ 0\\.11049047775090937\ \(0\)\
\-\ ultrasound\\:\\ 0\\.10947011744854893\ \(0\)\
\-\ cystic\\:\\ 0\\.10688739239770467\ \(0\)\
\-\ containing\\:\\ 0\\.10628594164965982\ \(0\)\
\-\ completely\\:\\ 0\\.10572279004417758\ \(0\)\
\-\ solid\\:\\ 0\\.090707644350623\ \(0\)\
\-\ removal\\:\\ 0\\.09044000868063404\ \(0\)\
\-\ sebum\\:\\ 0\\.09040229151978761\ \(0\)\
\-\ oftentimes\\:\\ 0\\.09040229151978761\ \(0\)\
\-\ mass\\:\\ 0\\.09038781722305306\ \(0\)\
\-\ commonly\\:\\ 0\\.08754884877087878\ \(0\)\
\-\ tumors\\:\\ 0\\.08701601089470748\ \(0\)\
\-\ and\\:\\ 0\\.08557060733861682\ \(0\)\
\-\ endodermal\\:\\ 0\\.08510465264839108\ \(0\)\
\-\ identified\\:\\ 0\\.08388321292377918\ \(0\)\
\-\ also\\:\\ 0\\.08347933920720439\ \(0\)\
\-\ endoderm\\:\\ 0\\.08321384349272574\ \(0\)\
\-\ laparoscopy\\:\\ 0\\.08161518713033625\ \(0\)\
\-\ ectoderm\\:\\ 0\\.08161518713033625\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.08054789918000425\ \(0\)\
\-\ mesoderm\\:\\ 0\\.08023036799987805\ \(0\)\
\-\ should\\:\\ 0\\.07720178911850169\ \(0\)\
\-\ histopathologic\\:\\ 0\\.07602539546566388\ \(0\)\
\-\ sweat\\:\\ 0\\.07442673910327438\ \(0\)\
\-\ adjunct\\:\\ 0\\.07442673910327438\ \(0\)\
\-\ in\\:\\ 0\\.0735835305359562\ \(0\)\
\-\ sebaceous\\:\\ 0\\.07304191997281619\ \(0\)\
\-\ derived\\:\\ 0\\.07241319788418897\ \(0\)\
\-\ amounts\\:\\ 0\\.07182042293144972\ \(0\)\
\-\ teratomas\\:\\ 0\\.0712597059279483\ \(0\)\
\-\ assist\\:\\ 0\\.07072775659426735\ \(0\)\
\-\ from\\:\\ 0\\.07048570248311843\ \(0\)\
\-\ ad\\:\\ 0\\.07022176656906022\ \(0\)\
\-\ immature\\:\\ 0\\.06973931966025307\ \(0\)\
\-\ cm\\:\\ 0\\.06795075482409252\ \(0\)\
\-\ laparotomy\\:\\ 0\\.06723829107621253\ \(0\)\
\-\ fibroids\\:\\ 0\\.06687436818113482\ \(0\)\
\-\ hair\\:\\ 0\\.06687436818113482\ \(0\)\
\-\ these\\:\\ 0\\.06681355142787067\ \(0\)\
\-\ vary\\:\\ 0\\.06652278406005317\ \(0\)\
\-\ identifying\\:\\ 0\\.06553434712603891\ \(0\)\
\-\ layers\\:\\ 0\\.0652247498571271\ \(0\)\
\-\ teeth\\:\\ 0\\.0652247498571271\ \(0\)\
\-\ bone\\:\\ 0\\.06455740449338943\ \(0\)\
\-\ endometrioma\\:\\ 0\\.06434782731283743\ \(0\)\
\-\ endocrine\\:\\ 0\\.06434782731283743\ \(0\)\
\-\ mucinous\\:\\ 0\\.06328322794358544\ \(0\)\
\-\ glands\\:\\ 0\\.06278928991081002\ \(0\)\
\-\ tissue\\:\\ 0\\.06206639444274446\ \(0\)\
\-\ staging\\:\\ 0\\.060427002370173684\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.05986628536667226\ \(0\)\
\-\ may\\:\\ 0\\.05954080975566418\ \(0\)\
\-\ contain\\:\\ 0\\.059162914967837585\ \(0\)\
\-\ to\\:\\ 0\\.05915799998215671\ \(0\)\
\-\ torsion\\:\\ 0\\.058994281360924085\ \(0\)\
\-\ right\\:\\ 0\\.05884043643874671\ \(0\)\
\-\ modality\\:\\ 0\\.058504234057258374\ \(0\)\
\-\ mobile\\:\\ 0\\.058345899098977035\ \(0\)\
\-\ of\\:\\ 0\\.05788524856981597\ \(0\)\
\-\ ovary\\:\\ 0\\.05788490150147747\ \(0\)\
\-\ tomography\\:\\ 0\\.05730047994292351\ \(0\)\
\-\ shadowing\\:\\ 0\\.057020172654442466\ \(0\)\
\-\ computed\\:\\ 0\\.057020172654442466\ \(0\)\
\-\ differentiated\\:\\ 0\\.056481311798799394\ \(0\)\
\-\ depending\\:\\ 0\\.05635086054014361\ \(0\)\
\-\ choice\\:\\ 0\\.056094779916523584\ \(0\)\
\-\ helpful\\:\\ 0\\.056094779916523584\ \(0\)\
\-\ nontender\\:\\ 0\\.05572213845151639\ \(0\)\
\-\ undergo\\:\\ 0\\.05524523887545468\ \(0\)\
\-\ uterine\\:\\ 0\\.05524523887545468\ \(0\)\
\-\ called\\:\\ 0\\.05524523887545468\ \(0\)\
\-\ degeneration\\:\\ 0\\.05501476853920355\ \(0\)\
\-\ standard\\:\\ 0\\.05490142600862978\ \(0\)\
\-\ neoplastic\\:\\ 0\\.05467839078201984\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.0544600513844783\ \(0\)\
\-\ echogenic\\:\\ 0\\.05424621415254698\ \(0\)\
\-\ unilateral\\:\\ 0\\.05414092656476286\ \(0\)\
\-\ components\\:\\ 0\\.053730150558485325\ \(0\)\
\-\ rarely\\:\\ 0\\.052769210074481356\ \(0\)\
\-\ predominantly\\:\\ 0\\.05180583333386222\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.05131578603019652\ \(0\)\
\-\ teratoma\\:\\ 0\\.05115745107191517\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.05054723164353995\ \(0\)\
\-\ incidentally\\:\\ 0\\.05040012650586897\ \(0\)\
\-\ is\\:\\ 0\\.04860284252733055\ \(0\)\
\-\ via\\:\\ 0\\.048352273466169986\ \(0\)\
\-\ be\\:\\ 0\\.047996448287165254\ \(0\)\
\-\ rupture\\:\\ 0\\.04782632051214169\ \(0\)\
\-\ as\\:\\ 0\\.047532109734800786\ \(0\)\
\-\ with\\:\\ 0\\.04633586799363451\ \(0\)\
\-\ evaluate\\:\\ 0\\.04600220443725855\ \(0\)\
\-\ routine\\:\\ 0\\.045812779293056265\ \(0\)\
\-\ cells\\:\\ 0\\.045580762047419496\ \(0\)\
\-\ complex\\:\\ 0\\.045580762047419496\ \(0\)\
\-\ attenuation\\:\\ 0\\.04526441870507634\ \(0\)\
\-\ reveals\\:\\ 0\\.04500074166315587\ \(0\)\
\-\ used\\:\\ 0\\.04428812786456874\ \(0\)\
\-\ skin\\:\\ 0\\.04400836073277524\ \(0\)\
\-\ 40\\:\\ 0\\.04350800544735374\ \(0\)\
\-\ risk\\:\\ 0\\.04226982177596677\ \(0\)\
\-\ iv\\:\\ 0\\.04226982177596677\ \(0\)\
\-\ malignant\\:\\ 0\\.04217026192346723\ \(0\)\
\-\ then\\:\\ 0\\.04187719173107361\ \(0\)\
\-\ complete\\:\\ 0\\.041467974460812754\ \(0\)\
\-\ or\\:\\ 0\\.041160353013044756\ \(0\)\
\-\ internal\\:\\ 0\\.039869318098423256\ \(0\)\
\-\ three\\:\\ 0\\.03971178486704273\ \(0\)\
\-\ initial\\:\\ 0\\.03968576041594486\ \(0\)\
\-\ such\\:\\ 0\\.03805373971919011\ \(0\)\
\-\ during\\:\\ 0\\.037470839309753735\ \(0\)\
\-\ usually\\:\\ 0\\.037242445451443285\ \(0\)\
\-\ yo\\:\\ 0\\.03695885290489395\ \(0\)\
\-\ evaluation\\:\\ 0\\.03607815064180878\ \(0\)\
\-\ on\\:\\ 0\\.03573374361809531\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03538591975946331\ \(0\)\
\-\ secondary\\:\\ 0\\.035064713924727285\ \(0\)\
\-\ however\\:\\ 0\\.03501489442946333\ \(0\)\
\-\ performed\\:\\ 0\\.03499834097292355\ \(0\)\
\-\ if\\:\\ 0\\.034372538163223505\ \(0\)\
\-\ distal\\:\\ 0\\.034372538163223505\ \(0\)\
\-\ cell\\:\\ 0\\.03384136744272812\ \(0\)\
\-\ common\\:\\ 0\\.03354962560775793\ \(0\)\
\-\ consistent\\:\\ 0\\.032077077654162664\ \(0\)\
\-\ follow\\:\\ 0\\.03189154965946777\ \(0\)\
\-\ associated\\:\\ 0\\.031180947225249136\ \(0\)\
\-\ imaging\\:\\ 0\\.031089775312165314\ \(0\)\
\-\ exam\\:\\ 0\\.0297804007709629\ \(0\)\
\-\ large\\:\\ 0\\.0296413274833134\ \(0\)\
\-\ but\\:\\ 0\\.02925395328802343\ \(0\)\
\-\ surgical\\:\\ 0\\.028752943644109703\ \(0\)\
\-\ contrast\\:\\ 0\\.028743890183630473\ \(0\)\
\-\ female\\:\\ 0\\.028546687834676055\ \(0\)\
\-\ lesion\\:\\ 0\\.028361884043656617\ \(0\)\
\-\ treatment\\:\\ 0\\.028180315833831786\ \(0\)\
\-\ seen\\:\\ 0\\.027851326234375015\ \(0\)\
\-\ an\\:\\ 0\\.022621998361209268\ \(0\)\
\-\ ct\\:\\ 0\\.022522182977397154\ \(0\)\
\-\ was\\:\\ 0\\.020617310679829248\ \(0\)\
\-\ this\\:\\ 0\\.020327913862737683\ \(0\)\
\-\ patient\\:\\ 0\\.019241278778019764\ \(0\)\
\-\ for\\:\\ 0\\.017930476659266954\ \(0\)\
